Dexcom CEO Kevin Sayer.Scott Mlyn | CNBCShares of Dexcom fell 9% in extended trading on Thursday after the company released third-quarter results that beat analysts’ expectations…

Dexcom shares sank more than 40% on Friday, their steepest decline ever, after the diabetes management company reported disappointing revenue for the second quarter and offered…